
Diabetes Diagnostics Market by Diabetes Type (Diabetes I, Diabetes II, Gestational Diabetes), Product (Biochips, Glucose Monitors, Kits), Diabetes Diagnostics Type, End-User - Global Forecast 2024-2030
Description
Diabetes Diagnostics Market by Diabetes Type (Diabetes I, Diabetes II, Gestational Diabetes), Product (Biochips, Glucose Monitors, Kits), Diabetes Diagnostics Type, End-User - Global Forecast 2024-2030
The Diabetes Diagnostics Market size was estimated at USD 20.37 billion in 2023 and expected to reach USD 21.91 billion in 2024, at a CAGR 7.80% to reach USD 34.48 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Diabetes Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Diabetes Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Diabetes Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Apex Biotechnology Corporation, ARKRAY, Inc., B. Braun Melsungen AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Diabetomics, Inc., Diazyme Laboratories Inc, F. Hoffmann-La Roche Ltd., ICON PLC, Medtronic PLC, Menarini Group, Nova Biomedical Corporation, Prestige Diagnostics, Sanwa Kagaku Kenkyusho Co, Ltd., Siemens Healthineers AG, Sinocare, Inc., Terumo Corporation, Tosoh Bioscience, Inc., and Trinity Biotech PLC.
Market Segmentation & Coverage
This research report categorizes the Diabetes Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Diabetes Type
Diabetes I
Diabetes II
Gestational Diabetes
Product
Biochips
Glucose Monitors
Kits
Lancets
Diabetes Diagnostics Type
Blood Glucose Test
Fasting Plasma Glucose Test
Glycated hemoglobin (A1C) Test
Oral Glucose Tolerance Test (OGTT)
End-User
Diagnostic Centers
Homecare Settings
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Diabetes Diagnostics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Diabetes Diagnostics Market?
3. What are the technology trends and regulatory frameworks in the Diabetes Diagnostics Market?
4. What is the market share of the leading vendors in the Diabetes Diagnostics Market?
5. Which modes and strategic moves are suitable for entering the Diabetes Diagnostics Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
180 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Diabetes Diagnostics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of diabetes with increasing geriatric population
- 5.1.1.2. Increasing trend of self-monitoring blood glucose levels at home
- 5.1.1.3. Government initiatives and public health campaigns to address diabetes
- 5.1.2. Restraints
- 5.1.2.1. High cost of diabetes diagnostic devices
- 5.1.3. Opportunities
- 5.1.3.1. Increasing adoption of point-of-care testing devices
- 5.1.3.2. Ongoing technological advancements in diabetes diagnostics and connectivity with digital health platforms
- 5.1.4. Challenges
- 5.1.4.1. Device accuracy and calibration issues with diabetes diagnostic device
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Diabetes Diagnostics Market, by Diabetes Type
- 6.1. Introduction
- 6.2. Diabetes I
- 6.3. Diabetes II
- 6.4. Gestational Diabetes
- 7. Diabetes Diagnostics Market, by Product
- 7.1. Introduction
- 7.2. Biochips
- 7.3. Glucose Monitors
- 7.4. Kits
- 7.5. Lancets
- 8. Diabetes Diagnostics Market, by Diabetes Diagnostics Type
- 8.1. Introduction
- 8.2. Blood Glucose Test
- 8.3. Fasting Plasma Glucose Test
- 8.4. Glycated hemoglobin (A1C) Test
- 8.5. Oral Glucose Tolerance Test (OGTT)
- 9. Diabetes Diagnostics Market, by End-User
- 9.1. Introduction
- 9.2. Diagnostic Centers
- 9.3. Homecare Settings
- 9.4. Hospitals
- 10. Americas Diabetes Diagnostics Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Diabetes Diagnostics Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Diabetes Diagnostics Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. 3M Company
- 14.1.2. Abbott Laboratories
- 14.1.3. Acon Laboratories, Inc.
- 14.1.4. AgaMatrix, Inc.
- 14.1.5. Apex Biotechnology Corporation
- 14.1.6. ARKRAY, Inc.
- 14.1.7. B. Braun Melsungen AG
- 14.1.8. Beckman Coulter, Inc.
- 14.1.9. Becton, Dickinson and Company
- 14.1.10. Bio-Rad Laboratories, Inc.
- 14.1.11. Danaher Corporation
- 14.1.12. Diabetomics, Inc.
- 14.1.13. Diazyme Laboratories Inc
- 14.1.14. F. Hoffmann-La Roche Ltd.
- 14.1.15. ICON PLC
- 14.1.16. Medtronic PLC
- 14.1.17. Menarini Group
- 14.1.18. Nova Biomedical Corporation
- 14.1.19. Prestige Diagnostics
- 14.1.20. Sanwa Kagaku Kenkyusho Co, Ltd.
- 14.1.21. Siemens Healthineers AG
- 14.1.22. Sinocare, Inc.
- 14.1.23. Terumo Corporation
- 14.1.24. Tosoh Bioscience, Inc.
- 14.1.25. Trinity Biotech PLC
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. DIABETES DIAGNOSTICS MARKET RESEARCH PROCESS
- FIGURE 2. DIABETES DIAGNOSTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DIABETES DIAGNOSTICS MARKET DYNAMICS
- FIGURE 7. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2023 VS 2030 (%)
- FIGURE 8. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 10. DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2023 VS 2030 (%)
- FIGURE 12. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.